-- Health care stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly higher and the iShares Biotechnology ETF (IBB) down 0.1%.
Abbott Laboratories (ABT) stock was down more than 3% after the company issued Q2 adjusted earnings per share guidance below analysts' expectations, and lowered its 2026 adjusted EPS outlook.
Hims & Hers Health (HIMS) shares were up more than 7% after a senior US health official signaled plans to ease restrictions on certain peptides.
Organon (OGN) is a potential acquisition target by India's Sun Pharmaceutical Industries, Germany's Grunenthal, and private equity firms, Bloomberg reported, citing unnamed people familiar with the matter. Organon shares were up more than 5% pre-bell.